The architecture of the body is not encoded as a formal blueprint; rather, it's the tightly orchestrated activation and ...
Caffeine could act as an on-off switch for gene and cell therapies, giving doctors more precise control over powerful ...
New research shows hibernating mammals protect muscle stem cells by suppressing activation, inflammation, and regeneration ...
A recent scientific study has highlighted the potential role of microRNAs in reducing stress and improving metabolic health, ...
The Gazette on MSN
Montreal-born author chronicles her family's inherited Holocaust trauma
Audrey Hyams Romoff remembered the moment her life “split in two” — before her parents were found dead together in their ...
Zacks Investment Research on MSN
Keros Therapeutics vs. Dyne: Which DMD biotech has more upside?
Keros Therapeutics KROS is a clinical-stage biopharmaceutical company developing innovative therapies for patients with disorders caused by abnormal signaling within the transforming growth ...
MedPage Today on MSN
Case Study: Strangely Elevated LDL Levels Persisting for Decades
Such a puzzle since the patient had neither CVD risk factors nor atherosclerotic changes ...
Why some memories persist while others vanish has fascinated scientists for more than a century. Now, new research from the ...
Several artists continue to distance themselves from the Trump-Kennedy Center for the Arts following President Donald Trump's ...
Arrowhead Pharmaceuticals, Inc. today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-DIMER-PA, the company's investigational RNA interference (RNAi) therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results